Re-reviewed `doi__10.3390_ijms19103041` and repaired the worker-2/4/6 layers.

Outcome: `accepted_with_cautions`, `publication_grade=true`, original ticket `rwk-complete-test-0001` closed.

Updated key artifacts:
- `paper_packets/.../analysis/activity_toxicity_evidence.json` and `papers/.../final/activity_toxicity_evidence.json`: 71 source-located rows, including Table 3 complete rebuild and Table 4 rowspan recovery.
- `paper_packets/.../analysis/database_record_audit.json` and `papers/.../final/database_record_verification.json`: 20 linked DBAASP rows, `source_verified=14`, `source_conflict=6`.
- `papers/.../final/review_report.json` and `papers/.../work/review/quality_feedback.json`: no open rework targets, `issue_count=0`.
- `paper_packets/.../rework/rework_responses.jsonl`: appended closure response with checked paths, repairs, cautions, and gate evidence.

Validation:
- Semantic gate: `pass=1`, `fail=0`, `issues=0`.
- Publication gate: `publication_grade_pass=true`, `risk_counts={}`.
- JSON/JSONL validation passed.

Remaining cautions are nonblocking and preserved: Buforin database identity is not primary-sequence verified, some database MBIC exact values are figure-derived rather than tabulated, mechanism evidence is limited to membrane assays, and no local supplementary assets exist.

